The Inflation Reduction Act (IRA) of 2022: What Pharmaceutical Manufacturers Need to Know

Mercalis in Motion
19/07/2023 31 min
The Inflation Reduction Act (IRA) of 2022: What Pharmaceutical Manufacturers Need to Know

Listen "The Inflation Reduction Act (IRA) of 2022: What Pharmaceutical Manufacturers Need to Know"

Descargar episodio

Episode Synopsis

The Drug Provisions within the Inflation Reduction Act (IRA) of 2022 are of critical importance to pharmaceutical manufacturers, who now have a host of new considerations when thinking through their portfolio strategies and pricing and market access considerations.  In this episode of TrialCard TALK, Landy and Eric welcome to the studio two experts on the topic: Megan Thomas, Partner, Triangle Insights Group and Jason Zemcik, Principal Consultant for Policy Reporter. 

More episodes of the podcast Mercalis in Motion

Mercalis Celebrates National Nurses Week 2025 07/05/2025
Optimizing HCP Engagement: Strategies for Every Stage of the Product Life Cycle 25/03/2025
Mercalis Executive Leadership Reflects on 2024 Successes and Future Strategy 04/03/2025
Lessons on Employee Engagement, Culture, and Inclusivity in the Post-Pandemic Workplace 17/01/2025
2024 in Review: Noteworthy Guests and Key Discussions 20/12/2024
Biosimilars and their Impact on Pharma Patient Support Services 25/11/2024
Mercalis Celebrates 15 Years of RxStudy Card 29/08/2024
Simplifying eServices with Mercalis’s Curator Solution 27/08/2024
The Mercalis Nurse Network 13/06/2024
Market Trends, AI Strategy, and More: A Conversation With Policy Reporter by Mercalis 14/05/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA